752687
Last Update Posted: 2010-10-21
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
100 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults
To evaluate the safety, tolerability and pharmacokinetics of ABT-072 in healthy volunteers and its anti-viral activity in HCV infected subjects.
A blinded, randomized, placebo-controlled trial to study the safety, tolerability, antiviral activity and pharmacokinetic profiles of ABT-072 in healthy and HCV genotype-1 infected adults.
Eligibility
Relevant conditions:
Hepatitis C
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov